TY - JOUR
T1 - Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease
AU - Iadecola, Costantino
AU - Goldman, Stephen S.
AU - Harder, David R.
AU - Heistad, Donald D.
AU - Katusic, Zvonimir S.
AU - Moskowitz, Michael A.
AU - Simard, J. Marc
AU - Sloan, Michael A.
AU - Traystman, Richard J.
AU - Velletri, Paul A.
PY - 2006/6
Y1 - 2006/6
N2 - The National Heart, Lung, and Blood Institute (NHLBI) convened a conference call working group, consisting of experts in stroke and cerebrovascular biology on January 28, 2005. The purpose of this working group was to develop a prioritized set of recommendations for NHLBI to establish a focused and comprehensive set of research activities in cerebrovascular biology and disease. Three thematic areas of research emerged: (1) molecular and cellular neurobiology of cerebral blood vessels, focusing on genomics and proteomics, neurovascular signaling and cerebrovascular embryogenesis, development and plasticity; (2) resource development, involving the development of new methodological approaches for normal and altered function of the neurovascular unit, collaborative research, and training in cerebrovascular pathobiology; and (3) cerebrovascular diseases and translational approaches, addressing vascular mechanisms of disease, the role of risk factors, importance of biomarkers with the ultimate goal of developing new treatments.
AB - The National Heart, Lung, and Blood Institute (NHLBI) convened a conference call working group, consisting of experts in stroke and cerebrovascular biology on January 28, 2005. The purpose of this working group was to develop a prioritized set of recommendations for NHLBI to establish a focused and comprehensive set of research activities in cerebrovascular biology and disease. Three thematic areas of research emerged: (1) molecular and cellular neurobiology of cerebral blood vessels, focusing on genomics and proteomics, neurovascular signaling and cerebrovascular embryogenesis, development and plasticity; (2) resource development, involving the development of new methodological approaches for normal and altered function of the neurovascular unit, collaborative research, and training in cerebrovascular pathobiology; and (3) cerebrovascular diseases and translational approaches, addressing vascular mechanisms of disease, the role of risk factors, importance of biomarkers with the ultimate goal of developing new treatments.
KW - Cerebrovascular disease
KW - Microcirculation
UR - http://www.scopus.com/inward/record.url?scp=33745141581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745141581&partnerID=8YFLogxK
U2 - 10.1161/01.STR.0000221297.57305.8a
DO - 10.1161/01.STR.0000221297.57305.8a
M3 - Article
C2 - 16627792
AN - SCOPUS:33745141581
SN - 0039-2499
VL - 37
SP - 1578
EP - 1581
JO - Stroke
JF - Stroke
IS - 6
ER -